Sinzinger et al., 1987 - Google Patents
Prostaglandin 12 reduces activation of human arterial smooth muscle cells in-vivoSinzinger et al., 1987
- Document ID
- 3066199861755624510
- Author
- Sinzinger H
- Zidek T
- Fitscha P
- O'Grady J
- Wagner O
- Kaliman J
- Publication year
- Publication venue
- Prostaglandins
External Links
Snippet
Patients suffering from peripheral vascular disease have been “ultima ratio”-treated with PGI2 at a rate of 5 ng/kg/min for 6 hours a day and 5 consecutive days iv 20 of them underwent surgery thereafter as therapy was not sufficient. A histological examination and …
- 210000000329 Myocytes, Smooth Muscle 0 title abstract description 8
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Yang et al. | Induction of myocardial nitric oxide synthase by cardiac allograft rejection. | |
| US6720340B1 (en) | Nicotine receptor agonists in stem cell and progenitor cell recruitment | |
| Strausser et al. | Prostaglandin synthesis inhibition: effect on bone changes and sarcoma tumor induction in BALB/c mice | |
| Yasuda et al. | Effect of prostaglandin E1 analogue TFC 612 on diabetic neuropathy in streptozocin-induced diabetic rats comparison with aldose reductase inhibitor ONO 2235 | |
| Rivner et al. | Kearns‐Sayre syndrome and complex II deficiency | |
| Godfried et al. | Potentiation of atherosclerotic lesions in rabbits by a high dietary level of vitamin E | |
| Weringer et al. | Effects of insulin on wound healing in diabetic mice | |
| WO1990011071A1 (en) | Angiogenic butyric acid analogs and their prodrugs | |
| Sinzinger et al. | Prostaglandin 12 reduces activation of human arterial smooth muscle cells in-vivo | |
| Eklund et al. | A controlled study showing significant short term effect of prostaglandin El in healing of ischaemic ulcers of the lower limb in man | |
| Honn et al. | Prostaglandin analogs as inhibitors of tumor cell DNA synthesis | |
| AU679818B2 (en) | Butyric ester cyto-differentiating agents | |
| Gschwendt et al. | The weak immunosuppressant cyclosporine D as well as the immunologically inactive cyclosporine H are potent inhibitors in vivo of phorbol ester TPA-induced biological effects in mouse skin and of Ca2+ calmodulin dependent EF-2 phosphorylation in vitro | |
| Koide et al. | Inhibition of experimental bone resorption and osteoclast formation and survival by 2-aminoethanesulphonic acid | |
| Harbrecht et al. | Prostanoids inhibit Kupffer cell nitric oxide synthesis | |
| JPH0570365A (en) | Wound healing compositions containing fibroblast growth factor and ascorbic acid | |
| US8163780B2 (en) | Nicotine receptor agonists in stem cell and progenitor cell recruitment | |
| Wengrovitz et al. | Cyclosporine inhibits the development of medial thickening after experimental arterial injury | |
| Kauhanen et al. | Satellite cell proliferation, reinnervation, and revascularization in human free microvascular muscle flaps1 | |
| MacLean | Substance P synthesis and transport in explants of nodose ganglion/vagus nerve: effects of double ligation, 2‐deoxyglucose, veratridine, and ouabain | |
| Matejka et al. | Evidence that PGI2-generationin human dental cysts is stimulated by leucotrienes C4 and D4 | |
| Tetzner et al. | Sister-chromatid exchange induction by metabolically activated retinoids in human diploid fibroblast cultures | |
| EP0862438A4 (en) | Use of sphingosylphosphorylcholine as a wound-healing agent | |
| Sinzinger et al. | PGE1 reduces collagen and glycosaminoglycan synthesis in rabbit aorta | |
| Bergenholtz et al. | The effect of diphenylhydantoin upon the biosynthesis and degradation of collagen in cat palatal mucosa in organ culture |